Lowering Blood Pressure in Primary Care in Vienna

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 229 participants.

Also called NCT02377661

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 229 participants (enrolled count) (from the registry)
Sponsor
Wilhelminenspital Vienna (from the registry)
Registry
  • NCT NCT02377661
Other papers using this trial's data
  • Lowering blood pressure in primary care in Vienna (LOW-BP-VIENNA) : A cluster-randomized trial Wiener klinische Wochenschrift, 2018-12 DOI, PubMed 30112584, PMC6290730 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02377661. Randomized; no masking; primary purpose treatment. Start 2015-03 (actual); primary completion 2017-05-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Lowering Blood Pressure in Primary Care in Vienna
Acronym
Low BP Vienna
Condition
Hypertension
Intervention (Drug)
Olmesartan medoxomil, amlodipine, hydrochlorothiazide
Lead sponsor
Wilhelminenspital Vienna (class: other)
Collaborator
Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology (class: other)
Collaborator
Ludwig Boltzmann Institute for Cardiovascular Research (class: other)

Record details

Record id
cardio:ct-nct02377661
Content hash
65334f004875c8536840d5fba2eba110af69ea135e482b8074c4dd3f9ac1c267